Gezielt nachschlagen
Suche
Suche startet nach einer kurzen Eingabepause.
20 angezeigte Treffer · Seite 6, keine Gesamtzahl für „Paediatric“
Suchtreffer
Begriffe & Kennungen
Amsparity · 4.8 · In controlled and open-label adult and paediatric studies with adalimumab, serious infections (including fatal
Eintrag öffnenAmsparity · 4.8 · In controlled and open-label adult and paediatric studies with adalimumab, serious infections (including fatal
Eintrag öffnenAmsparity · 4.8 · In general, the adverse events in paediatric patients were similar in frequency and type to those seen in adul
Eintrag öffnenAmsparity · 4.8 · In general, the adverse events in paediatric patients were similar in frequency and type to those seen in adul
Eintrag öffnenAmsparity · 4.8 · In general, the adverse events in paediatric patients were similar in frequency and type to those seen in adul
Eintrag öffnenAmsparity · 4.8 · In the Phase 3 trial of adalimumab in patients with paediatric Crohn’s disease which evaluated efficacy and sa
Eintrag öffnenAmsparity · 4.8 · In the Phase 3 trial of adalimumab in patients with paediatric Crohn’s disease which evaluated efficacy and sa
Eintrag öffnenAmsparity · 4.8 · In the Phase 3 trial of adalimumab in patients with paediatric Crohn’s disease which evaluated efficacy and sa
Eintrag öffnenAmsparity · 4.8 · In the controlled Phase 3 trial of adalimumab in patients with paediatric ulcerative colitis (N = 93) which ev
Eintrag öffnenAmsparity · 4.8 · No ALT elevations ≥ 3 x ULN occurred in the Phase 3 trial of adalimumab in paediatric patients with plaque pso
Eintrag öffnenAmsparity · 4.8 · No ALT elevations ≥ 3 x ULN occurred in the Phase 3 trial of adalimumab in paediatric patients with plaque pso
Eintrag öffnenAmsparity · 4.8 · No ALT elevations ≥3 x ULN occurred in the Phase 3 trial of adalimumab in paediatric patients with plaque psor
Eintrag öffnenAmsparity · 4.8 · No malignancies were observed in 249 paediatric patients with an exposure of 655.6 patient-years during adalim
Eintrag öffnenAmsparity · 4.8 · No malignancies were observed in 249 paediatric patients with an exposure of 655.6 patient-years during adalim
Eintrag öffnenAmsparity · 4.8 · No malignancies were observed in 249 paediatric patients with an exposure of 655.6 patient-years during adalim
Eintrag öffnenAmsparity · 4.8 · Paediatric population
Eintrag öffnenAmsparity · 4.8 · Paediatric population
Eintrag öffnenAmsparity · 4.8 · Paediatric population
Eintrag öffnenAnagrelide Viatris (previously Anagrelide Mylan) · 4.5 · Paediatric population
Eintrag öffnenAnagrelide Viatris (previously Anagrelide Mylan) · 4.8 · Paediatric population
Eintrag öffnen